Literature DB >> 8796926

Cardiovascular risk in women with polycystic ovarian syndrome.

D S Guzick1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8796926     DOI： 10.1055/s-2007-1016308

Source DB:  PubMed          Journal:  Semin Reprod Endocrinol        ISSN： 0734-8630


× No keyword cloud information.
  4 in total

1.  Role of metformin in the management of polycystic ovary syndrome.

Authors:  Hany Lashen
Journal:  Ther Adv Endocrinol Metab       Date:  2010-06       Impact factor: 3.565

2.  Polycystic ovary syndrome: a major unrecognized cardiovascular risk factor in women.

Authors:  Carolyn J Alexander; Edward P Tangchitnob; Norman E Lepor
Journal:  Rev Obstet Gynecol       Date:  2009

Review 3.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

4.  Study of early atherosclerotic markers in women with polycystic ovary syndrome.

Authors:  Ritu Karoli; Jalees Fatima; Zeba Siddiqi; Priti Vatsal; Amit R Sultania; Sumit Maini
Journal:  Indian J Endocrinol Metab       Date:  2012-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.